Results: 19
Leveraging plant-derived nanovesicles for advanced nucleic acid-based gene therapy.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 324, doi. 10.7150/thno.104507
- By:
- Publication type:
- Article
Targeting cancer with precision: strategical insights into TCR-engineered T cell therapies.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 300, doi. 10.7150/thno.104594
- By:
- Publication type:
- Article
A STING agonist prodrug reprograms tumor-associated macrophage to boost colorectal cancer immunotherapy.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 277, doi. 10.7150/thno.101001
- By:
- Publication type:
- Article
Inhibiting autophagy selectively prunes dysfunctional tumor vessels and optimizes the tumor immune microenvironment.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 258, doi. 10.7150/thno.98285
- By:
- Publication type:
- Article
tRNA-derived small RNAs in disease immunity.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 245, doi. 10.7150/thno.102650
- By:
- Publication type:
- Article
First clinical utility of sensing Ultrasound Localization Microscopy (sULM): identifying renal pseudotumors.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 233, doi. 10.7150/thno.100897
- By:
- Publication type:
- Article
Tumor immunomodulation by nanoparticle and focused ultrasound alters gut microbiome in a sexually dimorphic manner.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 216, doi. 10.7150/thno.99664
- By:
- Publication type:
- Article
Big data analytics and scRNA-seq in human aortic aneurysms and dissections: role of endothelial MerTK.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 202, doi. 10.7150/thno.103851
- By:
- Publication type:
- Article
A H2S-activated NIR-II imaging probe for precise diagnosis and pathological evaluation of colorectal tumor.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 189, doi. 10.7150/thno.103999
- By:
- Publication type:
- Article
Metabolism of cancer cells and immune cells in the initiation, progression, and metastasis of cancer.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 155, doi. 10.7150/thno.103376
- By:
- Publication type:
- Article
18F-5-fluoro-aminosuberic acid PET/CT imaging of oxidative-stress features during the formation of DEN-induced rat hepatocellular carcinoma.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 141, doi. 10.7150/thno.100467
- By:
- Publication type:
- Article
Optical coherence tomography (OCT) and OCT angiography: Technological development and applications in brain science.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 122, doi. 10.7150/thno.97192
- By:
- Publication type:
- Article
Development of dual aptamers-functionalized c-MET PROTAC degraders for targeted therapy of osteosarcoma.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 103, doi. 10.7150/thno.99588
- By:
- Publication type:
- Article
iRGD-TRP-PK1-modified red blood cell membrane vesicles as a new chemotherapeutic drug delivery and targeting system in head and neck cancer.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 86, doi. 10.7150/thno.99481
- By:
- Publication type:
- Article
Integrating oxygen-boosted sonodynamic therapy and ferroptosis via engineered exosomes for effective cancer treatment.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 68, doi. 10.7150/thno.102977
- By:
- Publication type:
- Article
Optical molecular imaging in oral- and oropharyngeal squamous cell carcinoma using a novel uPAR-targeting near-infrared imaging agent FG001 (ICG-Glu-Glu-AE105): An explorative phase II clinical trial.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 52, doi. 10.7150/thno.100042
- By:
- Publication type:
- Article
Revolutionizing drug delivery: low-intensity pulsed ultrasound (LIPUS)-driven deep penetration into hypoxic tumor microenvironments of cholangiocarcinoma.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 30, doi. 10.7150/thno.99981
- By:
- Publication type:
- Article
CXCR4-directed endoradiotherapy with [<sup>177</sup>Lu]Pentixather added to total body irradiation for myeloablative conditioning in patients with relapsed/refractory acute myeloid leukemia.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 19, doi. 10.7150/thno.101215
- By:
- Publication type:
- Article
CD63 as novel target for nanoemulsion-based <sup>19</sup>F MRI imaging and drug delivery to activated cardiac fibroblasts.
- Published in:
- Theranostics, 2025, v. 15, n. 1, p. 1, doi. 10.7150/thno.96990
- By:
- Publication type:
- Article